Jefferies Financial Group reiterated their hold rating on shares of Lufax (NYSE:LU – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. Jefferies Financial Group currently has a $3.20 price objective on the stock.
Separately, Bank of America cut their price objective on shares of Lufax from $5.22 to $2.75 and set a “neutral” rating on the stock in a report on Friday, August 23rd.
Check Out Our Latest Stock Analysis on LU
Lufax Stock Up 2.8 %
Lufax (NYSE:LU – Get Free Report) last posted its earnings results on Monday, October 21st. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.15). The firm had revenue of $789.93 million for the quarter. Lufax had a negative return on equity of 2.66% and a negative net margin of 8.70%. During the same quarter in the prior year, the firm posted $0.04 earnings per share. On average, research analysts predict that Lufax will post -0.09 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. Panagora Asset Management Inc. purchased a new stake in shares of Lufax during the 2nd quarter worth about $26,000. Sequoia Financial Advisors LLC bought a new position in Lufax in the 1st quarter worth approximately $60,000. PDS Planning Inc acquired a new position in shares of Lufax during the first quarter worth approximately $78,000. SG Americas Securities LLC acquired a new stake in shares of Lufax in the third quarter worth $66,000. Finally, Diversified Trust Co acquired a new stake in shares of Lufax in the first quarter worth $92,000. Institutional investors and hedge funds own 69.14% of the company’s stock.
About Lufax
Lufax Holding Ltd operates as a financial service empowering institution for small and micro businesses in China. The company offers loan products, including general unsecured loans and secured loans, as well as consumer finance loans. It also provides wealth management products, such as asset management plans, mutual fund products, private investment fund products, and trust products.
Featured Stories
- Five stocks we like better than Lufax
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- What is a buyback in stocks? A comprehensive guide for investors
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for Lufax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lufax and related companies with MarketBeat.com's FREE daily email newsletter.